University of Iowa Hospitals and Clinics
Heart Sensor Study
Champion: CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients
HF Pressure Measurement System
The primary hypothesis is that the TREATMENT group will have a significantly lower rate of HF-related hospitalizations than the CONTROL group. ( Time Frame: 6 months). This trial is closed to enrollment and is follow-up phase.
This trial is closed to enrollment and continues in follow up phase.
Cardiomyopathy Treatment Program
Cynthia Larew RN 319-356-1028 pager # 2123
We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.